UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

IL-33 facilitates rapid expulsion of the parasitic nematode Strongyloides ratti from the intestine via ILC2- and IL-9-driven mast cell activation

PLoS pathogens, 2020-12, Vol.16 (12), p.e1009121-e1009121

2020

Volltextzugriff (PDF)

Basophils are dispensable for the establishment of protective adaptive immunity against primary and challenge infection with the intestinal helminth parasite Strongyloides ratti

PLoS neglected tropical diseases, 2018-11, Vol.12 (11), p.e0006992-e0006992

2018

Volltextzugriff (PDF)

Limited role of mast cells during infection with the parasitic nematode Litomosoides sigmodontis

PLoS neglected tropical diseases, 2020-07, Vol.14 (7), p.e0008534-e0008534

2020

Volltextzugriff (PDF)

Filariae-Retrovirus Co-infection in Mice is Associated with Suppressed Virus-Specific IgG Immune Response and Higher Viral Loads

PLoS neglected tropical diseases, 2016-12, Vol.10 (12), p.e0005170-e0005170

2016

Volltextzugriff (PDF)

Foxp3⁺ regulatory T cells delay expulsion of intestinal nematodes by suppression of IL-9-driven mast cell activation in BALB/c but not in C57BL/6 mice

PLoS pathogens, 2014-02, Vol.10 (2), p.e1003913-e1003913

2014

Volltextzugriff (PDF)

Cisplatin, gemcitabine and treosulfan is effective in chemotherapy-pretreated relapsed stage IV uveal melanoma patients

Cancer chemotherapy and pharmacology, 2008-09, Vol.62 (4), p.685-688

2008

Volltextzugriff (PDF)

Funktion und regulation von mastzellen bei der immunantwort der maus (mus musculus; linnaeus, 1758) auf den darmparasiten strongyloides ratti (sandground, 1925)

Reitz, Martina

2016

Volltextzugriff (PDF)

Interleukin-9 promotes early mast cell-mediated expulsion of Strongyloides ratti but is dispensable for generation of protective memory

Scientific reports, 2018-06, Vol.8 (1), p.8636-11, Article 8636

2018

Volltextzugriff (PDF)

Predictive impact of retinoid X receptor-alpha-expression in renal-cell carcinoma

Cancer biotherapy & radiopharmaceuticals, 2004-06, Vol.19 (3), p.331-342

2004

Volltextzugriff (PDF)

Peripheral blood neutrophils as independent immunologic predictor of response and long-term survival upon immunotherapy in metastatic renal-cell carcinoma

Cancer biotherapy & radiopharmaceuticals, 2008-02, Vol.23 (1), p.129-134

2008

Volltextzugriff (PDF)

Basophils Are Dispensable for the Control of a Filarial Infection

ImmunoHorizons, 2018-09, Vol.2 (8), p.296-304

2018

Volltextzugriff (PDF)

regulatory T cells delay expulsion of intestinal nematodes by suppression of IL-9-driven mast cell activation in BALB/c but not in C57BL/6 mice

PLoS pathogens, 2014-02, Vol.10 (2)

2014

Volltextzugriff (PDF)

Long-Term Maintenance Therapy in Interferon-α2a/Interleukin-2-Pretreated Advanced Renal-Cell Carcinoma Patients

Cancer biotherapy & radiopharmaceuticals, 2006-06, Vol.21 (3), p.206-210

2006

Volltextzugriff (PDF)

Bleomycin, vinorelbine and trofosfamide in relapsed stage IV cutaneous malignant melanoma patients

Cancer chemotherapy and pharmacology, 2009-10, Vol.64 (5), p.901-905

2009

Volltextzugriff (PDF)

Foxp3+ Regulatory T Cells Delay Expulsion of Intestinal Nematodes by Suppression of IL-9-Driven Mast Cell Activation in BALB/c but Not in C57BL/6 Mice: e1003913

PLoS pathogens, 2014-02, Vol.10 (2)

2014

Volltextzugriff (PDF)

Age has no significant impact on overall survival and on treatment tolerability in relapsed stage IV cutaneous malignant melanoma patients receiving Cisplatin, Gemcitabine, and Treosulfan

American journal of clinical oncology, 2011-02, Vol.34 (1), p.2-5

2011

Volltextzugriff (PDF)

Abstract 4652: Identification and validation of a novel nine-gene signature predicting clinical outcome in malignant melanoma

Cancer research (Chicago, Ill.), 2010-04, Vol.70 (8_Supplement), p.4652-4652

2010

Volltextzugriff (PDF)

Long-term maintenance therapy in interferon-alpha2a/interleukin-2-pretreated advanced renal-cell carcinoma patients

Cancer biotherapy & radiopharmaceuticals, 2006-06, Vol.21 (3), p.206

2006

Volltextzugriff (PDF)

Thirteen‐year, long‐term efficacy of interferon 2α and interleukin 2‐based home therapy in patients with advanced renal cell carcinoma

Cancer, 2002-09, Vol.95 (5), p.1045-1050

2002

Volltextzugriff (PDF)

GM-CSF plus antigenic peptide vaccination in locally advanced melanoma patients

Cancer biotherapy & radiopharmaceuticals, 2007-08, Vol.22 (4), p.551-555

2007

Volltextzugriff (PDF)

Increased expression of the tumor suppressor PLZF is a continuous predictor of long-term survival in malignant melanoma patients

Cancer biotherapy & radiopharmaceuticals, 2008-08, Vol.23 (4), p.451-460

2008

Volltextzugriff (PDF)

Metastatic renal carcinoma long-term survivors treated with s.c. interferon-alpha and s.c. interleukin-2

Cancer biotherapy & radiopharmaceuticals, 2005-08, Vol.20 (4), p.410-416

2005

Volltextzugriff (PDF)

Fractional polynomials in a new metastatic renal carcinoma continuous prognostic index involving histology, laboratory, and clinical predictors

Cancer biotherapy & radiopharmaceuticals, 2007-12, Vol.22 (6), p.812-818

2007

Volltextzugriff (PDF)

Individualized synthetic peptide vaccines with GM-CSF in locally advanced melanoma patients

Cancer biotherapy & radiopharmaceuticals, 2004-12, Vol.19 (6), p.758-763

2004

Volltextzugriff (PDF)

Dose-dependent treatment benefit in high-risk melanoma patients receiving adjuvant high-dose interferon alfa-2b

Cancer biotherapy & radiopharmaceuticals, 2005-06, Vol.20 (3), p.280-289

2005

Volltextzugriff (PDF)

1 – 25 von 32

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(30)
Mit Volltextzugriff
(24)

Publikationsform

Artikel
(31)
Dissertationen
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(21)
Life Sciences & Biomedicine
(19)
Humans
(17)
Female
(14)
Male
(14)
Middle Aged
(14)
Adult
(12)
Oncology
(12)
Aged
(11)
Pharmacology & Pharmacy
(10)
Radiology, Nuclear Medicine & Medical Imaging
(9)
Medicine, Research & Experimental
(8)
Research & Experimental Medicine
(8)
Immunotherapy
(7)
Infections
(7)
Aged, 80 And Over
(6)
Immune System
(6)
Parasites
(6)
Risk Factors
(6)
Survival Rate
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

IL-33 facilitates rapid expulsion of the parasitic nematode Strongyloides ratti from the intestine via ILC2- and IL-9-driven mast cell activation

Basophils are dispensable for the establishment of protective adaptive immunity against primary and challenge infection with the intestinal helminth parasite Strongyloides ratti

Limited role of mast cells during infection with the parasitic nematode Litomosoides sigmodontis

Filariae-Retrovirus Co-infection in Mice is Associated with Suppressed Virus-Specific IgG Immune Response and Higher Viral Loads

Foxp3⁺ regulatory T cells delay expulsion of intestinal nematodes by suppression of IL-9-driven mast cell activation in BALB/c but not in C57BL/6 mice

Cisplatin, gemcitabine and treosulfan is effective in chemotherapy-pretreated relapsed stage IV uveal melanoma patients

Funktion und regulation von mastzellen bei der immunantwort der maus (mus musculus; linnaeus, 1758) auf den darmparasiten strongyloides ratti (sandground, 1925)

Interleukin-9 promotes early mast cell-mediated expulsion of Strongyloides ratti but is dispensable for generation of protective memory

Predictive impact of retinoid X receptor-alpha-expression in renal-cell carcinoma

Peripheral blood neutrophils as independent immunologic predictor of response and long-term survival upon immunotherapy in metastatic renal-cell carcinoma

Basophils Are Dispensable for the Control of a Filarial Infection

regulatory T cells delay expulsion of intestinal nematodes by suppression of IL-9-driven mast cell activation in BALB/c but not in C57BL/6 mice

Long-Term Maintenance Therapy in Interferon-α2a/Interleukin-2-Pretreated Advanced Renal-Cell Carcinoma Patients

Bleomycin, vinorelbine and trofosfamide in relapsed stage IV cutaneous malignant melanoma patients

Foxp3+ Regulatory T Cells Delay Expulsion of Intestinal Nematodes by Suppression of IL-9-Driven Mast Cell Activation in BALB/c but Not in C57BL/6 Mice: e1003913

Age has no significant impact on overall survival and on treatment tolerability in relapsed stage IV cutaneous malignant melanoma patients receiving Cisplatin, Gemcitabine, and Treosulfan

Abstract 4652: Identification and validation of a novel nine-gene signature predicting clinical outcome in malignant melanoma

Long-term maintenance therapy in interferon-alpha2a/interleukin-2-pretreated advanced renal-cell carcinoma patients

Thirteen‐year, long‐term efficacy of interferon 2α and interleukin 2‐based home therapy in patients with advanced renal cell carcinoma

GM-CSF plus antigenic peptide vaccination in locally advanced melanoma patients

Increased expression of the tumor suppressor PLZF is a continuous predictor of long-term survival in malignant melanoma patients

Metastatic renal carcinoma long-term survivors treated with s.c. interferon-alpha and s.c. interleukin-2

Fractional polynomials in a new metastatic renal carcinoma continuous prognostic index involving histology, laboratory, and clinical predictors

Individualized synthetic peptide vaccines with GM-CSF in locally advanced melanoma patients

Dose-dependent treatment benefit in high-risk melanoma patients receiving adjuvant high-dose interferon alfa-2b

Suchergebnisse filtern